Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: AR201
FAQ for Palforzia, the First FDA Approved Therapy for Food Allergy
Dave Bloom
-
2019/09/15
What it is, what it treats, who it is for, how it is used, et al.
Aimmune Enrolls First Patient in Phase 2 Trial of AR201 for...
News Wire ~ 3rd Party Press Release
-
2019/08/21
AR201 is the second development program that Aimmune is advancing to phase 2 using its Characterized Oral Desensitization ImmunoTherapy (CODIT™) platform.
Aimmune to Begin Phase 2 Trials of Egg Allergy OIT Candidate
News Wire ~ 3rd Party Press Release
-
2018/12/20
AR201 for Egg Allergy Phase 2 Initiation Planned for 2019.